Log in
ETR:CE2

CropEnergies Stock Forecast, Price & News

€11.66
+0.38 (+3.37 %)
(As of 10/30/2020 12:00 AM ET)
Add
Compare
Today's Range
€11.36
Now: €11.66
€12.02
50-Day Range
€11.30
MA: €13.75
€15.98
52-Week Range
€5.97
Now: €11.66
€16.26
Volume322,948 shs
Average VolumeN/A
Market Capitalization$1.02 billion
P/E Ratio12.38
Dividend Yield2.49%
BetaN/A
CropEnergies AG manufactures and distributes bioethanol and other biofuels, and related products produced from grain and other agricultural raw materials in Germany and internationally. The company produces and sells protein food and animal feed products, including ProtiGrain, a protein animal feed for various types of livestock and pets; wheat gluten for food and animal feed; and ProtiWanze, a liquid protein for cattle and pigs. It also offers liquefied carbonic acid; and produces neutral alcohol for beverage, food, cosmetics, and pharmaceutical industries, as well as for industrial applications. The company was founded in 2006 and is headquartered in Mannheim, Germany. CropEnergies AG is a subsidiary of Südzucker AG.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.96 out of 5 stars

Industry, Sector and Symbol

Industry Oil & Gas Integrated
Sub-IndustryN/A
SectorEnergy
CUSIPN/A
CIKN/A
Phone49 621 71 41 9000
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$850.76 million
Cash Flow€0.24 per share
Book Value€5.81 per share

Profitability

Miscellaneous

Market Cap$1.02 billion
Next Earnings DateN/A
OptionableNot Optionable
€11.66
+0.38 (+3.37 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CE2 News and Ratings via Email

Sign-up to receive the latest news and ratings for CE2 and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











CropEnergies (ETR:CE2) Frequently Asked Questions

How has CropEnergies' stock price been impacted by Coronavirus (COVID-19)?

CropEnergies' stock was trading at €8.17 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CE2 stock has increased by 42.7% and is now trading at €11.66.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of CropEnergies?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CropEnergies in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for CropEnergies
.

Who are some of CropEnergies' key competitors?

What other stocks do shareholders of CropEnergies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CropEnergies investors own include AbbVie (ABBV), ABIOMED (ABMD), Catalent (CTLT), Dynavax Technologies (DVAX), Hologic (HOLX), Merck & Co., Inc. (MRK), Net Element (NETE), Novavax (NVAX), Quanterix (QTRX) and Arca Biopharma (ABIO).

Who are CropEnergies' key executives?

CropEnergies' management team includes the following people:
  • Mr. Joachim Lutz, CEO & Member of Exec. Board (Age 63)
  • Stephan Meeder, CFO & Member of Exec. Board (Age 49)
  • Mr. Michael Friedmann, Chief Sales Officer & Member of Exec. Board (Age 64)

What is CropEnergies' stock symbol?

CropEnergies trades on the ETR under the ticker symbol "CE2."

What is CropEnergies' stock price today?

One share of CE2 stock can currently be purchased for approximately €11.66.

How big of a company is CropEnergies?

CropEnergies has a market capitalization of $1.02 billion and generates $850.76 million in revenue each year.

What is CropEnergies' official website?

The official website for CropEnergies is www.cropenergies.com.

How can I contact CropEnergies?

The company can be reached via phone at 49 621 71 41 9000.

This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.